Marex Group stock has more than doubled over the past year, yet the valuation signals are split, with the Excess Returns intrinsic value model suggesting the shares trade at a premium while the market multiple checks lean the other way.

• Marex Group has returned 108.2% over the past year, which puts extra focus on whether recent gains already reflect the good news in the price.
• Strong revenue growth across Marex Group's business segments can support bullish expectations, but an active acquisition program may also introduce integration and execution risks for future cash flows.
• Marex Group scores 3 out of 6 on our valuation checks, which points to a mixed picture rather than a clear bargain or clear overvaluation.

For investors, the debate is whether Marex Group's share price already factors in its recent growth or if the current premium to the Excess Returns intrinsic value estimate still leaves room for upside.

Does Marex Group Look Pricey on Excess Returns?

The Excess Returns model looks at how much profit Marex Group earns on its equity compared with the return that investors require. It then projects those excess profits on a per share basis. For Marex Group, the inputs are a Book Value of $18.94 per share and a Stable EPS of $5.96 per share, based on the median return on equity from the past 5 years. The model applies a Cost of Equity of $3.76 per share, which leaves an Excess Return of $2.21 per share on an Average Return on Equity of 21.55%.

Those excess profits are projected on a Stable Book Value of $27.67 per share, using weighted future book value estimates from 2 analysts, to arrive at an intrinsic value of about $50 per share. With the current Marex Group share price implying a 43.8% premium to this Excess Returns estimate, the stock screens as overvalued on this approach. Because the company recently reported 39% revenue growth and a Q2 earnings beat, the market may be paying up for the recent performance relative to what this model assumes is sustainable.

On the Excess Returns view, Marex Group stock currently looks overvalued relative to the earnings power implied by its equity base.

Our Excess Returns analysis suggests Marex Group may be overvalued by 43.8%. Discover 50 high quality undervalued stocks or create your own screener to find better value opportunities.

Is Marex Group Still Cheap on Earnings?

P/E fits Marex Group well because earnings are a key driver for most capital markets stocks. On this measure, Marex Group trades on a P/E of 13.8x, which is below both the Capital Markets industry average of 38.2x and the peer average of 22.0x. That already places the stock at a discount to many listed competitors that investors can compare against today.

The fair P/E ratio for Marex Group, which blends its sector, size and risk profile, is 16.8x. This is higher than the current 13.8x level, so the market price implies a discount to what this tailored benchmark suggests could be reasonable. In other words, the stock price does not fully reflect the level of earnings that Marex Group is currently generating, even after the strong 2026 Q2 results.

On the P/E multiple, Marex Group stock currently screens as undervalued compared with both its own fair ratio and broader sector benchmarks.

The Marex Group Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Marex Group pick up where this valuation split leaves off and spell out what kind of growth, margins and earnings path would need to play out for the stock to be worth materially more or materially less than today’s price on the Community page. Rather than focusing on a single multiple or model result, each Narrative lays out the assumptions behind its view of fair value so you can compare them with Marex Group's actual results as they are reported.

The community view on Marex Group is pulled in two very different directions, with one camp focused on expansion and another on pressure from a tougher operating backdrop.

Bull case: roughly fairly valued

"Ongoing M&A activity, particularly the transformative Winterflood acquisition and a robust pipeline of smaller deals, will drive both revenue and margin synergies through product/geographic diversification, cross-selling, and operational scale, positively impacting topline and earnings stability..."

Bear case: 64% overvalued

"Rapid revenue and profit growth in the most recent quarters has been heavily supported by an above normal operating environment with elevated market activity, volatility, and surging exchange volumes, as market conditions mean-revert and volatility subsides, revenue growth and margins are likely to slow sharply, eroding the current top end profitability..."

Do you think there's more to the story for Marex Group? Head over to our Community to see what others are saying!

The Bottom Line

The Excess Returns intrinsic value estimate points to Marex Group trading at a premium, while the P/E multiple suggests the stock is undervalued against peers and its own fair ratio. That split reflects different emphases. The intrinsic view leans on funding needs, the timing of cash flows and how capital intensive the business is. The market multiple view focuses more on growth expectations and current sentiment toward comparable capital markets stocks. From here, the key question is whether Marex Group can turn its recent revenue growth and acquisitions into durable earnings without eroding returns on equity, or whether the current discount on earnings is a sign of a value trap.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.